SAMSUNG EPIS HOLDINGS Co., Ltd. (삼성에피스홀딩스(주))
KOSPI Stock Code: 0126Z0 | DART Corp Code: 01965324
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | SAMSUNG EPIS HOLDINGS Co., Ltd. |
|---|---|
| Korean legal name | 삼성에피스홀딩스(주) |
| Alternate names | 삼성에피스홀딩스 |
| Market | KOSPI |
| Stock Code | 0126Z0 |
| DART Corp Code | 01965324 |
| CEO | 김경아 |
| Business Registration No. | 7598803316 |
| Corporate Registration No. | 1201110149508 |
| Established Date | 2025-11-03 |
| Fiscal Month | 12 |
| KSIC Industry Code | 64992 |
| Address (KO) | 인천광역시 연수구 송도교육로 76 삼성에피스홀딩스 |
| Homepage | https://www.samsungepisholdings.com/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260515003119 |
| verified_at | 2026-11-01T02:28:05.338Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260515003119
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 251,689,950,548 | N/A |
| Operating Income (영업이익) | KRW -63,640,615,999 | N/A |
| Net Income (당기순이익) | KRW 85,313,155,522 | N/A |
| Total Assets (자산총계) | KRW 7,715,584,325,302 | N/A |
| Total Liabilities (부채총계) | KRW 1,809,815,283,137 | N/A |
| Total Equity (자본총계) | KRW 5,905,769,042,165 | N/A |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-30 | 20261030801097 | Material Business Matters Related to Investment Decisions(Subsidiary's material business matters) (SB27(Keytruda 바이오시밀러) 미국 품목허가 신청) | 투자판단관련주요경영사항(자회사의 주요경영사항) (SB27(Keytruda 바이오시밀러) 미국 품목허가 신청) | 삼성에피스홀딩스 |
2026-10-28 | 20261028800403 | Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure) | 연결재무제표기준영업(잠정)실적(공정공시) | 삼성에피스홀딩스 |
2026-10-28 | 20261028800401 | Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)(Subsidiary's material business matters) | 연결재무제표기준영업(잠정)실적(공정공시)(자회사의 주요경영사항) | 삼성에피스홀딩스 |
2026-10-21 | 20261021800142 | Response to Rumors or Media Reports: Undetermined(Subsidiary's material business matters) | 풍문또는보도에대한해명(미확정)(자회사의 주요경영사항) | 삼성에피스홀딩스 |
2026-10-14 | 20261014800360 | Prior Notice on Disclosure of Final Earnings | 결산실적공시예고(안내공시) | 삼성에피스홀딩스 |
2026-10-06 | 20261006800422 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | 삼성에피스홀딩스 |
2026-10-01 | 20261001800667 | Material Business Matters Related to Investment Decisions(Subsidiary's material business matters) (중증 호산구 천식 치료제 SB41(Fasenra 바이오시밀러) 및 유전성 재발열 증후군 치료제 SB44(Ilaris 바이오시밀러) 파트너십 계약 체결) | 투자판단관련주요경영사항(자회사의 주요경영사항) (중증 호산구 천식 치료제 SB41(Fasenra 바이오시밀러) 및 유전성 재발열 증후군 치료제 SB44(Ilaris 바이오시밀러) 파트너십 계약 체결) | 삼성에피스홀딩스 |
2026-09-28 | 20260928800466 | [Corrected description]Details of Corporate Governance Report | [기재정정]기업지배구조보고서공시 | 삼성에피스홀딩스 |
2026-09-07 | 20260907800490 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | 삼성에피스홀딩스 |
2026-08-31 | 20260831000441 | Disclosure of Current Status of Large-scale Business Groups [Quarterly Disclosure (For individual company)] | 대규모기업집단현황공시[분기별공시(개별회사용)] | 삼성에피스홀딩스 |
2026-08-14 | 20260814002990 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | 삼성에피스홀딩스 |
2026-08-14 | 20260814000262 | Matters concerning payment amount for each payment method-payment period and Dispute Resolution Organization | 지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항 | 삼성에피스홀딩스 |
2026-08-10 | 20260810800530 | Material Business Matters Related to Investment Decisions(Subsidiary's material business matters) (SB27주(펨브롤리주맙 바이오시밀러) 한국 품목허가 신청) | 투자판단관련주요경영사항(자회사의 주요경영사항) (SB27주(펨브롤리주맙 바이오시밀러) 한국 품목허가 신청) | 삼성에피스홀딩스 |
2026-08-04 | 20260804800465 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | 삼성에피스홀딩스 |
2026-08-04 | 20260804000330 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 김형준 |
2026-08-04 | 20260804000327 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | KIM KYUNG-AH |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260515003119 | verified_at: 2026-11-01T02:28:05.338Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.